ZANTE GREG (Chief Financial Officer) received a stock award from VIKING THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Common Stock, par value $0.00001 per share
Shares
+20.23K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
−19.70K
Price / share
$9.40
Trade value
$185.15K
% of position
Common Stock, par value $0.00001 per share
Shares
+90.67K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
−23.93K
Price / share
$8.52
Trade value
$203.91K
% of position
Common Stock, par value $0.00001 per share
Shares
−20.71K
Price / share
$8.42
Trade value
$174.36K
% of position
Net shares
+46.56K
Net value
-$563.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 12/30/2022 | A · Award | +20.23K | — | — | 14.6% | 138.50K | 158.73K |
| Common Stock, par value $0.00001 per share Direct | 12/30/2022 | F · Tax Withholding | −19.70K | $9.40 | $185.15K | 12.4% | 158.73K | 139.03K |
| Common Stock, par value $0.00001 per share Direct | 1/3/2023 | A · Award | +90.67K | — | — | 65.2% | 139.03K | 229.70K |
| Common Stock, par value $0.00001 per share Direct | 1/3/2023 | F · Tax Withholding | −23.93K | $8.52 | $203.91K | 10.4% | 229.70K | 205.76K |
| Common Stock, par value $0.00001 per share Direct | 1/4/2023 | F · Tax Withholding | −20.71K | $8.42 | $174.36K | 10.1% | 205.76K | 185.06K |
| Total | +46.56K | -$563.42K | ||||||
Stock Option (Right to Buy)
Common Stock
204K shares
Shares
+204K
Strike price
8.52
Held after
204K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock204K shares | 1/3/2023 | A · Award | +204K | 8.52 | — | 204K |